These results demonstrated a synergistic effect on cell viability between β-catenin activation and BRCA1/2 deficiency, therefore providing a mechanism for the mutual exclusivity observed in breast tumours between gene mutations that promote oncogenic β-catenin activation and BRCA1/2 gene mutations (Supplementary Fig. 1e). This evidence concerns the gene BRCA1 and breast neoplasm.